205 related articles for article (PubMed ID: 25492964)
1. Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.
Sudol M
Sci Signal; 2014 Dec; 7(355):pe29. PubMed ID: 25492964
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
Haskins JW; Nguyen DX; Stern DF
Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
[TBL] [Abstract][Full Text] [Related]
3. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
[TBL] [Abstract][Full Text] [Related]
4. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction.
Liang X; Ding Y; Zhang Y; Chai YH; He J; Chiu SM; Gao F; Tse HF; Lian Q
Cell Death Dis; 2015 May; 6(5):e1765. PubMed ID: 25996292
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of the Hippo-YAP pathway in multiple cancer contexts.
Kim HB; Myung SJ
BMB Rep; 2018 Mar; 51(3):119-125. PubMed ID: 29366445
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.
Zhang J; Smolen GA; Haber DA
Cancer Res; 2008 Apr; 68(8):2789-94. PubMed ID: 18413746
[TBL] [Abstract][Full Text] [Related]
7. The Hippo-YAP signaling pathway and contact inhibition of growth.
Gumbiner BM; Kim NG
J Cell Sci; 2014 Feb; 127(Pt 4):709-17. PubMed ID: 24532814
[TBL] [Abstract][Full Text] [Related]
8. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
9. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.
Li X; Liu Y; Zhang C; Niu Q; Wang H; Che C; Xie M; Zhou B; Xu Y; Zhang Q; Wu J; Tian Z
Oncotarget; 2017 Mar; 8(10):16356-16366. PubMed ID: 28099921
[TBL] [Abstract][Full Text] [Related]
10. ErbB4 protects against neuronal apoptosis via activation of YAP/PIK3CB signaling pathway in a rat model of subarachnoid hemorrhage.
Yan F; Tan X; Wan W; Dixon BJ; Fan R; Enkhjargal B; Li Q; Zhang J; Chen G; Zhang JH
Exp Neurol; 2017 Nov; 297():92-100. PubMed ID: 28756200
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Hippo Pathway Transcription Factor TEAD.
Lin KC; Park HW; Guan KL
Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
[TBL] [Abstract][Full Text] [Related]
12. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
13. An update on targeting Hippo-YAP signaling in liver cancer.
Liu AM; Xu Z; Luk JM
Expert Opin Ther Targets; 2012 Mar; 16(3):243-7. PubMed ID: 22335485
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.
Yu FX; Zhao B; Panupinthu N; Jewell JL; Lian I; Wang LH; Zhao J; Yuan H; Tumaneng K; Li H; Fu XD; Mills GB; Guan KL
Cell; 2012 Aug; 150(4):780-91. PubMed ID: 22863277
[TBL] [Abstract][Full Text] [Related]
15. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
Nguyen HT; Kugler JM; Cohen SM
PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
[TBL] [Abstract][Full Text] [Related]
16. The Ambivalent Function of YAP in Apoptosis and Cancer.
Zhang X; Abdelrahman A; Vollmar B; Zechner D
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486435
[TBL] [Abstract][Full Text] [Related]
17. Two faces of Hippo: activate or suppress the Hippo pathway in cancer.
Cao J; Huang W
Anticancer Drugs; 2017 Nov; 28(10):1079-1085. PubMed ID: 28926422
[TBL] [Abstract][Full Text] [Related]
18. A connection between phosphatidylinositol 5-phosphate and the Hippo pathway to prevent epithelial-mesenchymal transition in cancer.
Hirsch E; Fantastico E; Prever L; Gulluni F
Sci Signal; 2024 May; 17(838):eadp3504. PubMed ID: 38805585
[TBL] [Abstract][Full Text] [Related]
19. AAK1 identified as an inhibitor of neuregulin-1/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomics.
Kuai L; Ong SE; Madison JM; Wang X; Duvall JR; Lewis TA; Luce CJ; Conner SD; Pearlman DA; Wood JL; Schreiber SL; Carr SA; Scolnick EM; Haggarty SJ
Chem Biol; 2011 Jul; 18(7):891-906. PubMed ID: 21802010
[TBL] [Abstract][Full Text] [Related]
20. YAP and WWTR1: New targets for skin cancer treatment.
Andl T; Zhou L; Yang K; Kadekaro AL; Zhang Y
Cancer Lett; 2017 Jun; 396():30-41. PubMed ID: 28279717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
